Apellis Pharmaceuticals
Why Robinhood?
You can watch APLS and buy or sell other stocks, ETFs, and their options commission-free!About APLS
Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE.
APLS Key Statistics
Stock Snapshot
As of today, Apellis Pharmaceuticals(APLS) shares are valued at $41.03. The company's market cap stands at 5.25B, with a P/E ratio of 41.01.
On 2026-06-01, Apellis Pharmaceuticals(APLS) stock opened at —, reached a high of —, and a low of —.
Apellis Pharmaceuticals(APLS) shares are trading with a volume of 0, against a daily average of 8.56M.
During the past year, Apellis Pharmaceuticals(APLS) stock moved between $16.61 at its lowest and $41.14 at its peak.
During the past year, Apellis Pharmaceuticals(APLS) stock moved between $16.61 at its lowest and $41.14 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.